Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Vautia Therapeutics ApS
APS
Active
Advertising protection
CVR 45465578
Frederiksgade 11, 1265
København K
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2025 · 1 year old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Vautia Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2025
Income statement
DKK thousands
Item
2025
Gross profit
-17
Staff expenses
-0
EBITDA
-17
Depreciation & amort.
-0
EBIT
-17
Net financials
-0
Profit before tax
-17
Tax
-0
Net profit
-17
Balance sheet
DKK thousands
Item
2025
Total assets
37
Equity
23
Long-term debt
0
Short-term debt
14
Total debt
14
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-1705600.0%
This company
2025
2025
Equity ratio
62.0%
This company
38.2%
Market median
+62% vs market
2025
2025
Return on equity
-74.4%
This company
18.4%
Market median
-504% vs market
2025
2025
Net profit margin (of gross profit)
-1705800.0%
This company
2025
2025
Asset turnover (of gross profit)
-0.46×
This company
2025
2025
Debt / equity
0.61×
This company
0.62×
Market median
+2% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-03-11 – 2025-12-31
View
PDF
More on Vautia Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
